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To the Editor
Golekoh et al1 reported adrenal insufficiency (AI) in 10% of children with eosinophilic 
esophagitis treated with swallowed glucocorticoids for ≥6 months and suggest screening this 
population with low-dose adrenocorticotropic hormone stimulation testing (LDST). 
Although this report provides important information on an at-risk population, we have 
concerns with the way the LDST was performed and thus question the rate of AI reported. 
Cortisol was measured only once after administration of synthetic adrenocorticotropic 
hormone at 20 minutes.
Peak cortisol tends to be earlier with LDST (1 μg) compared with high-dose (250 μg) 
stimulation testing, with the greatest mean cortisol concentrations occurring at 30 
minutes.2,3 Additional studies have shown that the peak cortisol concentration during LDST 
may occur at 30 minutes, 35 minutes, 40 minutes, or even up to 60 minutes.4–6 Cartaya and 
Misra6 retrospectively examined the results of LDST in 82 pediatric patients and found that 
54% attained a peak cortisol at 60 minutes. Importantly, 11 patients who did not pass at 30 
minutes did so at 60 minutes. In addition, children who were normal weight or underweight 
tended to peak at 60 minutes (P = .01), and in the study by Golekoh et al,1 patients with 
abnormal responses to LDST had significantly lower body mass index z scores compared 
with those with a normal response. Therefore, because cortisol values were not measured at 
later time points, children in the study by Golekoh et al1 may have been misclassified as 
having AI.
The timing of cortisol sampling is important to correctly interpret a LDST. Assessment with 
just a 20-minute cortisol value can result in over diagnosis of AI and an increased number of 
false positives, leading to unnecessary treatment with maintenance or stress glucocorticoids 
and potentially lead to unwanted side effects.
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